Leronlimab is an investigational drug that has not
Post# of 148236
(Total Views: 644)
Posted On: 03/04/2022 4:20:33 PM
Leronlimab is an investigational drug that has not been approved by the US FDA for the treatment of COVID-19 or for any other indication.
CytoDyn is in the process of updating the company's website to provide current information on the status of our development of leronlimab for the indications for which it is being studied.
CytoDyn website updated. Looks like this is a direct response to the FDA letter.
CytoDyn is in the process of updating the company's website to provide current information on the status of our development of leronlimab for the indications for which it is being studied.
CytoDyn website updated. Looks like this is a direct response to the FDA letter.
(3)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼